Aspirin dosing in cardiovascular disease prevention and management: an update

2014 ESC/EACTS Guidelines on myocardial revascularization

(2014)   EUROPEAN HEART JOURNAL

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors

(2014) Yasuo Ikeda et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

Use of Aspirin for Primary and Secondary Cardiovascular Disease Prevention in the United States, 2011–2012

(2014) Arch G. Mainous et al.   Journal of the American Heart Association

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Optimizing the Use of Aspirin for Cardiovascular Prevention

(2013) Rubén Casado-Arroyo et al.   DRUGS

2013 ESC guidelines on the management of stable coronary artery disease

(2013)   EUROPEAN HEART JOURNAL

Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?

(2013) C. Patrono   EUROPEAN HEART JOURNAL

Aspirin in Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review of the Balance of Evidence from Reviews of Randomized Trials

(2013) Paul Sutcliffe et al.   PLoS One

Prior Antiplatelet Use and Cardiovascular Outcomes in Patients Presenting with Acute Coronary Syndromes

(2012) Ayman El-Menyar et al.   American Journal of Cardiovascular Drugs

Effect of Aspirin on Vascular and Nonvascular Outcomes

(2012) Sreenivasa Rao Kondapally Seshasai   ARCHIVES OF INTERNAL MEDICINE

Primary and Secondary Prevention of Cardiovascular Disease

(2012) Per Olav Vandvik et al.   CHEST

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

(2012) Stephan D. Fihn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2012) Patrick T. O'Gara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin for Primary Prevention of Cardiovascular Disease Events

(2012) Carrie W. Nemerovski et al.   PHARMACOTHERAPY

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary

(2011) Alan D. Bell et al.   CANADIAN JOURNAL OF CARDIOLOGY

Aspirin

(2011) Valentin Fuster et al.   CIRCULATION

Forecasting the Future of Cardiovascular Disease in the United States

(2011) Paul A. Heidenreich et al.   CIRCULATION

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

(2011) et al.   EUROPEAN HEART JOURNAL

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

(2011) Glenn N. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

(2010) Shamir R Mehta et al.   LANCET

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET